Dr. dr. Karina, SpBP-RE
Biomedis
30 April 1974
RIWAYAT HIDUP :
| Nama Lengkap (dengan gelar) | : Dr. dr. Karina, SpBP-RE |
| Jenis Kelamin | : Perempuan |
| Jabatan Fungsional/Golongan | : Lektor |
| NIP/NIK/Identitas lainnya | : 2010901123 |
| NIDN | : 0030047410 |
| Tempat dan Tanggal Lahir | : Jakarta, 30 April 1974 |
| : dr.karina@upnvj.ac.id | |
| Alamat Kantor | : Jl.RS Fatmawati Pondok Labu Jakarta Selatan 12450 |
RIWAYAT PENDIDIKAN :
| NO | Pendidikan | Tahun |
| 1 | S1 Kedokteran, Universitas Indonesia | 1997 |
| 2 | S2 Departemen Bedah, Divisi Bedah Plastik, Universitas Indonesia | 2007 |
| 3 | S3 Ilmu Biomedis, Universitas Indonesia | 2019 |
Deskripsi Bidang Keilmuan/Kepakaran :
Biomedis Bedah Plastik
Penelitian :
| NO | Judul | TAHUN |
| 1 | Wound healing in stage IV pressure injury with use of adjunct autologous activated platelet-rich plasma therapy: a case report | 2023 |
| 2 | Safety and Efficacy of Mesenchymal Stem Cells in Burn Therapy: Systematic Review | 2022 |
| 3 | Therapeutic Effect of Autologous Activated Platelet-rich Plasma Therapy on Mid-dermal to Full-thickness Burns: A Case Series. | 2022 |
| 4 | Efficacy of Stromal Vascular Fraction and Platelet-Rich Plasma Therapy on Post-COVID-19 Nephrotic Syndrome in Diabetic Type 1 Patient: A Case Report | 2022 |
| 5 | Evaluation effects of ascorbic acid leads to activate and induce osteogenic protein marker expression: in silico and in-vitro study | 2022 |
| 6 | Autologous Activated Platelet-Rich Plasma Therapy for Pregnant COVID-19 Patients: A Case Series | 2022 |
| 7 | Case Report on Adjunct Intravenous Autologous Activated Platelet-Rich Plasma Therapy in Severely Ill COVID-19 Patients | 2021 |
| 8 | Evaluation of plasma PDGF and VEGF levels after systemic administration of activated autologous platelet-rich plasma | 2021 |
| 9 | The Effect of Intravenous Autologous Activated Platelet-Rich Plasma Therapy on “Profibrotic Cytokine” IL-1β Levels in Severe and Critical COVID-19 Patients: A Preliminary Study. | 2021 |
| 10 | Evaluating the Safety of Intravenous Delivery of Autologous Activated Platelet-Rich Plasma (aaPRP). | 2021 |
| 11 | Phase I/II Clinical Trial of Autologous Activated Platelet-rich Plasma (aaPRP) in the Treatment of Severe Coronavirus Disease 2019 (COVID-19) Patients | 2021 |
| 12 | Efficacy of Adipose-Derived Stem Cells as a Potential Cellular Therapy of Alzheimer: A Comprehensive Systematic Review | 2021 |
| 13 | Cleft Lip and/or Palate Patient Profile in Hayandra Peduli Foundation, Indonesia: A 5-Year Descriptive Study. | 2021 |
| 14 | In vivo study of wound healing processes in Sprague-Dawley model using human mesenchymal stem cells and platelet-rich plasma | 2021 |
| 15 | Primary Advanced Stage Non-Smoking Human Lung Cancer Peripheral Blood Mononuclear Cells Count. | 2021 |
| 16 | Potential Breakthrough for Treating Severe Coronavirus Disease-2019 (COVID-19) Patients in Intensive Care Unit: The Use of Autologous Activated Platelet-rich Plasma in Serial Cases of Indonesian Patients | 2021 |
Publikasi Artikel Ilmiah :
| NO | JUDUL | JENIS | TANGGAL TERBIT |
| 1 | Wound healing in stage IV pressure injury with use of adjunct autologous activated platelet-rich plasma therapy: a case report | Q1 | Januari 2023 |
| 2 | Therapeutic Effect of Autologous Activated Platelet-rich Plasma Therapy on Mid-dermal to Full-thickness Burns: A Case Series. | Q2 | Mei 2022 |
| 3 | Efficacy of Stromal Vascular Fraction and Platelet-Rich Plasma Therapy on Post-COVID-19 Nephrotic Syndrome in Diabetic Type 1 Patient: A Case Report | Q4 | Mei 2022 |
| 4 | Autologous Activated Platelet-Rich Plasma Therapy for Pregnant COVID-19 Patients: A Case Series | Q4 | Maret 2022 |
| 5 | Case Report on Adjunct Intravenous Autologous Activated Platelet-Rich Plasma Therapy in Severely Ill COVID-19 Patients | Oktober 2021 | |
| 6 | Evaluation of plasma PDGF and VEGF levels after systemic administration of activated autologous platelet-rich plasma | Q4 | September 2021 |
| 7 | The Effect of Intravenous Autologous Activated Platelet-Rich Plasma Therapy on “Profibrotic Cytokine” IL-1β Levels in Severe and Critical COVID-19 Patients: A Preliminary Study. | Q2 | Juli 2021 |
| 8 | Evaluating the Safety of Intravenous Delivery of Autologous Activated Platelet-Rich Plasma (aaPRP). | Q3 | September 2021 |
| 9 | Phase I/II Clinical Trial of Autologous Activated Platelet-rich Plasma (aaPRP) in the Treatment of Severe Coronavirus Disease 2019 (COVID-19) Patients | Q2 | Juli 2021 |
| 10 | Potential Breakthrough for Treating Severe Coronavirus Disease-2019 (COVID-19) Patients in Intensive Care Unit: The Use of Autologous Activated Platelet-rich Plasma in Serial Cases of Indonesian Patients | Q4 | Januari 2021 |